Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Protox Therapeutics Inc T.PRX



TSX:PRX - Post by User

Protox Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by nugieon Aug 24, 2009 1:29pm
418 Views
Post# 16244225

I R James Beasley

I R James BeasleyGood morning fellahs. Cabbie, your post of Aug 18 was read with a great deal of interest, and according to James your perspective is on the spot! The Prostrate Cancer trials are on a bit of a hold at the moment due to the success of the BPH trials and the quicker future of this aspect.
If anyone reading this wants more info, feel free to call James at 604 484 0975 and build your confidence and your investment due diligence from there.
We are going to be doing well in the last quarter my friends,

Nugie
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities